SANGE CAPITAL ApS: Financial statements 2025
CVR: 43515586
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SANGE CAPITAL ApS (CVR 43515586) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -6,169 and a net result of DKK -6,919 compared with DKK -5,300 the year before. Equity in the 2025 report amounted to DKK -19,609.
- Gross Profit
- DKK -6,169
- Profit/Loss
- DKK -6,919
- Equity
- DKK -19,609
- Total Assets
- DKK 11
- Employees
- 0
Official annual report
How creditworthy is SANGE CAPITAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
SANGE CAPITAL ApS has published its annual report for 2024. Gross profit came to DKK -5,300, and the net result was DKK -5,300.
About SANGE CAPITAL ApS
SANGE CAPITAL ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Sangevan Sayananthan. The company is owned by Sangevan Sayananthan. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,169 and a net result of DKK -6,919 compared with DKK -5,300 the year before. Equity in the 2025 report amounted to DKK -19,609.